3V Medical Research Group is developing Luxsol^™, a suspension intended for use as a targeted therapy to prevent and treat Covid-19 and Influenza, and Ostrolux^™, a cream intended to manage pain associated with osteoarthritis and the severe discomfort of radiation dermatitis .

3V Medical Research Group is committed to developing treatments for these common conditions for everyone without undesirable side effects.

Our Mission

Developing medical products based upon simple molecules and well understood drug delivery mechanisms, with a strong commitment to safety based upon well-designed clinical studies. Delivering treatments for conditions that are common, debilitating, and destroy quality of life for too many people.